Search

everythinglearnresearchcommunity

for

Search:↓

The HATMSC1 cell line from fat tissue can produce helpful factors for regenerative and immune therapies.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

Understanding the genetics of alopecia areata could lead to better treatments.

PRP may help reduce brain inflammation and protect brain cells.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

IL-27 can prevent hair loss in alopecia areata.

HYDRO DELUXE BIO hyaluronic acid hydrogel is compatible with skin cells, may reduce inflammation, promote blood vessel growth, and protect against oxidative stress, suggesting it could help revitalize hair follicles.

Hidradenitis suppurativa is a chronic skin disorder linked to genetics, lifestyle, and immune issues, treatable with medication and sometimes surgery.

Hidradenitis suppurativa is a chronic skin disorder linked to genetics, lifestyle, and immune issues, treatable with medications and surgery.

Matrix changes and increased MMPs contribute to skin inflammation in hidradenitis suppurativa.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Scientists now better understand how human hair growth is controlled, including the roles of specific genes and proteins.

A soluble factor in developing mouse whisker pads boosts nerve growth factor mRNA production.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

cp-asiAR may effectively treat androgenetic alopecia by promoting hair growth and reducing androgen receptor activity.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Certain inflammatory factors may increase or decrease the risk of developing PCOS.

Magnesium oxide-infused membranes help heal wounds faster by reducing inflammation and promoting skin and hair follicle growth.

Dihydrotestosterone treatment on 2D and 3D-cultured skin cells slows down hair growth by affecting certain genes and could be a potential target for hair loss treatment.

PDGF signaling may play a role in hair growth cycle regulation.

New liposomal formulations may improve delivery of treatments to hair follicles, potentially helping with hair loss.

Epidermal keratinocytes start wound healing and inflammation after schistosome infection.

MMP-9 increase in hair follicles may lead to hair loss.

NLRP1 helps melanoma tumors grow by boosting inflammasome activation and reducing caspase-3 activity.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.